
Halle C. F. Moore, MD
Advertisement
Articles by Halle C. F. Moore, MD


This video reviews a meta-analysis that looked at five studies testing the use of a gonadotropin-releasing hormone (GnRH) analog to protect ovarian function and preserve fertility in premenopausal women undergoing chemotherapy for early-stage breast cancer.

This review will focus largely on the effects of systemic cytotoxic treatment on cognitive function, reflecting what has been most extensively studied in the literature.
Advertisement
Latest Updated Articles
An Overview of Chemotherapy-Related Cognitive Dysfunction, or ‘Chemobrain’Published: September 15th 2014 | Updated:
Meta-Analysis: GnRH Analog Preserves Ovarian Function in Early Breast CancerPublished: December 14th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies
2
Median OS Not Yet Reached With New Immunotherapy Combo in 2L Glioblastoma
3
FDA Accepts NDA for Gedatolisib in HR+/HER2–, PIK3CA Wild-Type Breast Cancer
4
FDA Issues Guidance on MRD, CR Outcomes for Multiple Myeloma Approvals
5
